For example, experimental data have shown that enrichment of CD8+ TRM within tumor sites is linked to improved responses to PD-1 inhibitors, and those microbial indicators are essential for the maintenance and activation of these cells [217]. The gene discussed is CD8A; the disease is neoplasm.